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To perform cardiac imagingin mice withouthavingto invest in expensive dedicated equipment, we adapted a clinical 1.5Tesla (T)
magnetic resonance imaging (MRI) scanner for use in a murine ischemia/reperfusion model. Phase-sensitive inversion recovery
(PSIR) sequence facilitated the determination of infarct sizes in vivo by late gadolinium enhancement. Results were compared to
histological infarct areas in mice after ischemia/reperfusion procedure with a good correlation (r = 0.807, P<. 001). In addition,
fractional area change (FAC) was assessed with single slice cine MRI and was matched to infarct size (r =− 0.837) and fractional
shortening (FS) measured with echocardiography (r = 0.860); both P<. 001. Here, we demonstrate the use of clinical 1.5 MRI
scanners as a feasible method for basic phenotyping in mice. These widely available scanners are capable of investigating in vivo
infarct dimensions as well as assessmentof cardiac functional parameters in mice with reasonable throughput.
1.Background
In cardiovascular research, the use of mouse models is
gaining importance, based on the widespread utilization of
genetically altered mice [1]a n dd i ﬀerent disease models
[2]. Due to small heart size and high heart rate, most
cardiac imaging methods in mice have the disadvantage of
requiring specialized and expensive equipment. Therefore,
clinical echocardiography systems are the most frequently
used investigative tool [3] in murine cardiac imaging,
since dedicated animal echocardiography machines are not
available in most institutions.
Recently, cardiac magnetic resonance imaging (CMR)
has developed into a highly demanded imaging method
in mice, because it provides measurements of a range of
diﬀerent parameters [4]. Many experiments have been con-
ducted with specialized high-ﬁeld (4.7 Tesla (T) to 17.6T)
magnetic resonance imaging (MRI)scanners, demonstrating
them to be a valuable imaging method for cardiovascular
research [5–9]. However, these devices specialized for small
animal imaging, are expensive and not accessible to most
researchers. Although few experiments on mice have been
conducted using standard 1.5T MRI [10–13], hardware and
imaging techniques have advanced in the meanwhile.
Wesoughttodevelopaneasilyaccessiblebutversatileand
accurate cardiac imaging method with adequate throughput
for an ischemia/reperfusion (I/R) model [14]i nm i c eb y
adapting a widely available 1.5T MRI scanner with standard
equipment provided by the manufacturer. The purpose of
this study was to determine whether (a) it is possible to
use late enhancement sequences [15] to detect myocardial
infarction in the mouse heart at 1.5T, (b) this method
can detect diﬀerences in infarct size and whether results
correlate with histological infarct size and (c) 1.5T scanners
can provide measurements of functional parameters to
characterize the normal and impaired mouse heart.
Here, we evaluate the feasibility of standard 1.5T MRI
to determine infarct size in vivo. Additionally, we tested2 Journal of Biomedicine and Biotechnology
theacquisitionofquicklyobtainableMRI-derivedfunctional
measurements to characterize heart function.
2.Methods
2.1. Mouse Ischemia/Reperfusion Model. Our investigation
was carried out in two study groups. The ﬁrst group
comprising a total of 25 C57BL/6 mice, 12–15 weeks
old, were randomized into subgroups of 0min = sham
(n = 6), 30min (n = 10) and 60min of ischemia (n = 9)
resulting in diﬀerent infarction size. Mice underwent a well-
established in vivo procedure of reversible LAD ligation
as previously described [16–18] followed by 1 week of
reperfusion. Brieﬂy, following anesthesia, ventilation, and
thoracotomy, the LAD was reversibly ligated aided by a PE
tube. After the deﬁned duration of ischemia, the PE tube
was removed and reperfusion was visually conﬁrmed. Three
hours after reperfusion, troponin T was evaluated using
a quantitative assay (Roche Diagnostics, Austria); 1 week
after reperfusion, imaging procedures were performed and
mice were sacriﬁced and the hearts excised for histological
evaluation of infarct size. In a second study group (n = 18)
similar to the ﬁrst one (sham: n = 6, 30min: n = 6a n d
60min: n = 6),images were acquired and hearts were excised
for histological evaluation ofinfarct size. Photoshop (Adobe,
United States) software was used to create artwork. CMR
images were enlarged to ﬁt format. Animals were obtained
from Charles River Laboratories and handled in accordance
with institutional guidelines; all experiments were approved
by the Institutional Ethics Committee and in accordance
with the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996).
2.2.Histology. Hearts fromthe ﬁrst study group were excised
for histological evaluation after 1 week of reperfusion. Three
5-μmsectionswerecutin1mmdistancefromtheapextothe
mid-section of the left ventricle for standard hematoxylin-
eosin and Masson trichrome staining to detect collagen
deposition and scar size. Slices were digitized with Axiom II
(Zeiss, Germany), and infarct size was analyzed with Image J
software from trichrome stainings [19].
Hearts from the second study group were excised after
24h of reperfusion for triphenyl tetrazolium chloride (TTC)
staining. TTC staining was performed to assess myocardial
viability before scar formation. Whereas brick red areas
indicate viable myocardium, white regions demarcate tissue
injury. Hearts were cut in 1mm thick slices which were
digitized and analyzed with Image J software. Diﬀerent
staining protocols for the two groups were required due to
diﬀerent reperfusion times to permit infarct evaluation [6].
Infarct size was calculated in percentage of left ventricular
myocardial area.
2.3. MRI Image Acquisition. Measurements were performed
using a 1.5T routine whole body MR scanner (Magnetom
Avanto, Siemens, Germany) equipped with a 40mT/m
gradient system. In the ﬁrst study group, MRI examinations
were performed before I/R procedure, 24h and 1 week after
procedure. In the second study group, late enhancement
imaging was performed 24h after procedure. Because of the
essential noncardiodepressive characteristics of the widely
used 222-tribromoethanol [20, 21], this sedative was used
in this experiment, despite the known possible side eﬀects
[20, 22–24]. None of the mice showed any sign of the
described side eﬀects after intraperitoneal administration of
250mg/kg 222-tribromoethanol at a dilution of 12.5mg/ml.
After sedation and injection of contrast agent, mice were
placed prone inside a small loop coil (standard ﬁnger
coil) with an inner diameter of 30mm (see Supplementary
Material available online at doi:10.1155/2011/185683).Mean
heart rateduringexaminations was 410±70beatsperminute
(bpm). For electrocardiography (ECG) gating, the standard
equipment as provided by the MRI manufacturer was used:
Siemens wireless peripheral monitoring unit attached to
paws with trimmed Skintact conductor pads for children.
Localizing protocols were performed, followed by functional
measurements, and imaging was completed by acquisition
of late enhancement sequences. Total acquisition time was
approximately 20min. Images were analyzed using JVision
software (Agfa, Germany).
2.4. Cine MRI. After using localizers to determine heart
axis (See supplemental ﬁle 2), a short-axis single slice cine
imaging was performed atpapillary muscle levelofthe heart,
mirroring echocardiographic imaging procedure, followed
by a long-axis scan (See supplemental ﬁles 3, 4 and 5). For
cine imaging (Figure 2), a 2D-FLASH sequence was used
(repetition time (TR) = 13ms, echo time (TE) = 6.2ms,
ﬂip angle: 15◦, number of slices: 1, slice thickness: 2mm,
number of excitations: 4; ﬁeld of view: 90mm × 62mm and
an acquisition matrix of 256×141). An average of 12 cardiac
phases was acquired (acquisition time was about 3min),
and fractional area change (FAC) and fractional shortening
(FS)were determined from these images. Thereafter, a short-
axis cine imaging (number of excitations: 1; slice thickness:
1.5mm) with 3-4 subsequent slice positions covering the
whole left ventricle was performed for calculation of ejection
fraction. EjectionfractionwascalculatedwithSiemensArgus
software [25] (See supplementary material). FAC and FS
(measured parallel and perpendicular to the septum) were
calculated using the standard formula (FS: ((LV enddiastolic
diameter − LV endsystolic diameter)/LV enddiastolic diam-
eter) ∗ 100; FAC ((LV enddiastolic area − LV endsystolic
area)/LV enddiastolic area) ∗ 100).
2.5. Late Enhancement Imaging. Gadolinium-DOTA was
administered intravenously before imaging procedure. Best
results were obtained when concentration of the contrast
agent used was 0.6mmol/kg and LGE measurements were
conducted 20min after administration at the end of the
imaging routine [7, 26, 27].
After registering cine MRI sequences, a segmented 2D
phase-sensitive inversion recovery trueFISP sequence (PSIR)
[25, 26]( Figure 1) with the following parameters was used:
TR = 328ms; TE = 2.72ms; ﬂip angle: 45◦;i n v e r s i o nt i m eJournal of Biomedicine and Biotechnology 3
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Figure 1: Myocardial infarction shown by LGE in magnetic resonance imaging and histological staining. Representative slices taken from
the left ventricle: LGE shown by phase-sensitive inversion recovery trueFISP sequence (PSIR) (a) compared with 3 successive slices from the
same heart after triphenyl tetrazolium chloride staining (b) 24h after procedure. LGE shown by PSIR sequence (c) compared with 3 slices
from the same heart after trichrome staining(d) 1 week after procedure. Arrows indicate area of infarction.
(TI)= 320ms; slicethickness:2.5mm; ﬁeldofview: 80mm×
72mm; acquisition matrix: 256 × 168. The parameters
were chosen such that data acquisition took place during
the R-R interval in order to minimize artifacts caused by
heart motion. The typical acquisition time was 60 seconds.
Additionally, an ECG-gated 3D inversion recovery-prepared
single shot gradient-echo sequence (turbo fast low angle
shot, turboFLASH)was used covering the whole heart with a
slice thickness of 0.8mm (see supplemental ﬁle 7). Typical
acquisition parameters were as follows: TR = 437ms, TE
= 5.78ms, TI = 270ms, ﬂip angle: 15◦, acquisition matrix:
384×512, FOV: 56mm ×75mm. Fat saturation was used to
suppress the fat signal.
2.6. Echocardiography. Echocardiographic examinations
were performed 3 to 4h after MRI imaging; mice were
again sedated with 250mg/kg 222-tribromoethanol.
Myocardial contractility was determined by transthoracic
echocardiography (See supplementary material), using a
clinical echocardiography system (Acuson Sequoia C512,
Acuson Corporation, United States) with Acuson15 L8
transducer (15Mhz). FS was calculated from short-axis
2D-targetedM-mode images of the left ventricle[3].Average
heart rate during echocardiography was 518 ± 60bpm.
2.7. Statistical Analysis of Data. Statistical tests were per-
formed with SPSS 15.0 software. Data were analyzed using
one way ANOVA test followed by post hoc multiple com-
parison test; for correlation the Pearson correlation test was
used. All data are expressed as mean ± standard deviation.
Probability values <.05 were considered signiﬁcant.
3.Results
3.1. Evaluation of Infarct Size. T h r e em i c ew e r ee x c l u d e d
from the study due to poor image quality and were not
included in the numbers of mice in the study. In every
mouse of the 30 and 60min ischemia group, myocardial
infarction was detectedby CMR and histology. Noinfarction
was found in sham mice. Furthermore, the 60-min ischemia
group had signiﬁcantly larger infarct sizes than the 30-
min group determined by either CMR PSIR sequences or
histology (Table 1). We found no signiﬁcant diﬀerence of
infarct size measured with CMR and histological meth-
ods.
In the ﬁrst study group (1 week reperfusion), correlation
of histological observers was r = 0.793 and r = 0.807,
both P<. 001 (Figure 3) demonstrating good interobserver
agreement of r = 0.806, P<. 001 (sham mice excluded).
Troponin T values correlated reasonably well with infarct
size (1W) determined by either CMR LGE (r = 0.684,
P = .007) or histological staining (r = 0.628, P = .016);
sham mice excluded.
Furthermore, the second study group (24h reperfu-
sion) revealed good correlation of LGE imaging with their4 Journal of Biomedicine and Biotechnology
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Figure 2: Short-axis cine magnetic resonance imaging of the mouse heart. Mouse heart in cardiac cine magnetic resonance imaging 1 week
after sham operation ((a):diastolic, (b): systolic) and 60min ischemia ((c): diastolic, (d): systolic).
Table 1: Infarct size in mouse heart after I/R procedure. Infarct
size measured in magnetic resonance imaging by LGE in magnetic
resonance imaging and histology (24h after reperfusion by TTC
staining and 1 week after reperfusion by trichrome staining). No
infarction was detected in sham-operated mice. Values shown as
mean percentage of left ventricular area ± standard deviation.
∗Signiﬁcant diﬀerence to 30min ischemia operated mice, all P<
.05.
30min 60min
Infarction area histology (TTC)
24h (%)
17.7 ±4.33 3 .1 ±7.1
∗
Infarction area LGE 24h (%) 20.6 ±7.83 7 .1 ±8.7
∗
Infarction area histology
(trichrome) 1W (%)
15.9 ±7.73 5 .6 ±15.2
∗
Infarction area LGE 1W (%) 18.3 ±4.43 8 .3 ±10.2
∗
respective TTC stainings (r = 0.793, P = .002; sham mice
excluded).
3.2. Cardiac Functional Parameters. Cardiac function
(Table 2) determined by FAC measured in cine MRI
correlated well with FS measured in echocardiography
(correlation of all measurements: before procedure, 24h
and 1 week after procedure: r = 0.860, P<. 001). A
signiﬁcant diﬀerence in cardiac function was found between
the groups (Figure 3). Comparison of FS measured by CMR
and echocardiography showed a correlation of r = 0.820,
P<. 001; correlation between FS and FAC measured by
CMR was r = 0.863, P<. 001.
3.3. Correlation of Infarct Size with Functional Parameters.
Correlation of histological infarct size 1 week after pro-
cedure with functional parameters was CMR-determined
FAC r =− 0.837, CMR-determined FS r =− 0.768 and
echocardiography-determined FS r =− 0.782; all P<. 001.
Infarct size determined by LGE in MRI also showed good
correlations with functional parameters: CMR-determined
FAC r =− 0.860, CMR-determined FS r =− 0.758, and
echocardiography-determined FS r =− 0.845; all P<. 001.
Troponin T levels correlated to functional measurements
revealed similar results: Troponin T correlated to FAC
(CMR): r =− 0.781, P<. 001; FS (CMR) r =− 0.735,
P<. 001; FS (Echocardiography) r =− 0.663, P = .001.
4.Discussion
The following are the three major ﬁndings of this study.
(a) It is possible to use late enhancement sequences to
determine infarct size in mice with a clinical MRI scanner;
(b) Infarct size measured with MRI shows good correlation
with histological infarct size; (c) Functional parameters
determined with cine MRI show good correlation with
infarct size and standard echocardiography.Journal of Biomedicine and Biotechnology 5
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Figure 3: Regressionplot showinginfarct sizeand functionalparameters. Regression plotofinfarctsize (a)measured inmagneticresonance
imaging with LGE (Y axis) compared with histological infarct size in TTC staining (X axis) 24h after procedure (a—circles, broken line).
Infarct size determined by magnetic resonance imaging (Y axis) compared with histological infarct size in trichrome staining (X axis) 1
week afterprocedure (a—rhombi,continuous line).Regressionplot offunctionalparameters (b):fractionalarea change(FAC) (b—rhombi,
continuous line) and fractional shortening (FS) (b—circles, broken line) measured in cine magnetic resonance imaging (Y axis) compared
with fractional shortening (FS) measured with echocardiography (X axis).
To ease access to murine cardiac imaging, we successfully
adapted a clinical 1.5T MRI scanner for in vivo phenotyping
using a mouse ischemia/reperfusion model.
Weﬁrsttestedtheuseoflateenhancement[15]sequences
for in vivo infarct size quantiﬁcation in C57Bl/6 mice
after I/R procedure and validated it by comparing it with
histological infarct size. Clinical scanners, however, lack
the spatial and temporal resolution required for detailed
imaging. This results in the lower correlation of our MRI
LGE measurements and histology when compared with
results from dedicated rodent scanners [27]. However, our
results indicate that a good estimate of infarct size in mice in
vivo is possible on a clinical scanner. The PSIR rather than
a FLASH-3D sequence was chosen for evaluation of infarct
size because of its relative resistance to motion artifacts, at
the cost of higher slice thickness.
In agreement with other investigations [12, 13], there
was a good correlation between the results of functional
measurements by cine CMR and the established standard
echocardiography in mice. The good correlation of impaired
cardiac function with infarction size and the diﬀerence of
cardiac function found between the diﬀerent reperfusion
groups highlight the capability of clinical MRI to detect
functional diﬀerences between the normal and impaired
mouse heart.
FS is the established parameter to characterize LV
function in mice and, measured by MRI, shows good
correlation to echocardiographic measurements of FS and
infarct size. Due to localizing protocols, MRI permits easy
standardization of imaging procedures allowing for more
advanced techniques routinely used. Ejection fraction was
already shown useful elsewhere [13]a n ds i m i l a rr e s u l t s6 Journal of Biomedicine and Biotechnology
were achieved in this study (See supplementary material).
Sincemeasurement of EF is time consuming and challenging
on a 1.5T MRI scanner, we investigated the use of FAC to
describecardiacfunction.FACshowed goodcorrelationwith
infarct size that was even better than FS. This suggests that,
while measurement of EF is the proper standard, single slice
measurement of FAC can give a good estimate of myocardial
function impaired by I/R injury, and at the same time,
is a simple, robust, and fast imaging modality for
routine use.
We were able to acquire these data without expensive
specialized equipment. To our knowledge, this was not
possible prior to the establishment of this imaging protocol.
The ability of clinical MRI scanners to acquire versatile
information, with good correlation to established methods,
demonstrates its capacity to characterize the extent of
myocardial infarction and cardiac functions in mice. Higher
ﬁeld strength MRI scanners are traditionally used in murine
models, and clinical 1.5T MRI scanners are of limited value
inthisareaofresearch. Anadaptedclinicalscannerobviously
cannot perform as well as specialized rodent scanners [6,
27]. However, as our data indicate, this imaging method
can provide a valuable imaging alternative for basic cardiac
phenotyping. If imaging sequences are reduced to those
discussed here (localizing sequences, followed by a short-
axis cine sequence and PSIR sequence), image acquisition
of the mouse heart can be accomplished in approximately
6-7min.
Experiments conducted on 1.5T MRI by other inves-
tigators used diﬀerent settings for slice thickness and ﬁeld
of view, at the cost of temporal resolution, obtainable
cardiac phases and therefore of image quality [12, 13].
The results from these studies already hinted at the
potential of adapting clinical scanners. Advances in hard-
ware and modiﬁed sequences enabled us to improve our
settings for the representation of cardiac function while
minimizing artifacts.
3T MRI scanners, available in future in an increasing
number of institutions [11], can be adapted in the same
manner as shown here and may provide even better imaging
quality. However, this study was performed on a 1.5T MRI
to demonstrate the potential of clinical scanners.
In clinical MRI scanners, high heart rate in mice
can cause motion artifacts in PSIR sequence when using
segmentation factors >10 (typical patient examination: seg-
mentation factor: 65 [25, 28]), mimicking LGE. To prevent
this, ECG gating and MRI protocols should be optimized,
images should be interpreted by trained observers and
sedation should be adequate [29]. While a low heart rate is
beneﬁcial for LGE sequences, measurements of functional
parameters require a heart rate close to physiological con-
dition [30]. During MRI measurements, mean heart rate
of the animals was lower than during echocardiographic
measurements. This may be due to the diﬀerent environ-
ment in the MRI scanner. Nonetheless, in the absence
of dedicated animal echocardiography machines, a clinical
MRI scanner employed in accordance with the protocol we
present in this study, can provide valuable imaging data for
basic cardiac phenotyping.
Table 2: Cardiac functional parameters. Fractional shortening (FS)
determined by echocardiography and cine magnetic resonance
imaging (MRI), fractional area change (FAC) determined by cine
magnetic resonance imaging. Values shown as mean percentage
± standard deviation before (preop), 24h and 1 week after
ischemia/reperfusion procedure for mice with no ischemia (sham),
30min or 60min of ischemia during procedure. Troponin T levels
(ng/ml) are shown for each group. ∗Signiﬁcant diﬀerence to sham-
operated mice; †Signiﬁcant diﬀerence to 60min operated mice; all
P<. 05.
0min= sham 30min 60min
FS echo preop (%) 50.8 ±3.75 0 .5 ±3.15 1 .5 ±3.6
FS MRI preop (%) 48.2 ±5.14 7 .5 ±5.34 7 .4 ±3.6
FAC preop (%) 55.5 ±5.45 5 .7 ±6.35 2 .5 ±2.7
FS echo 24h (%) 51 ±5.5
† 41.1 ± 5.6
∗ 40.7 ±3.6
∗
FS MRI 24h (%) 45.8 ±8.6
† 33.1 ± 9.7
∗ 26.2 ±4.6
∗
FAC 24 h (%) 55.3 ±6.9
† 42.8 ± 6.9
∗ 38.6 ±3.6
∗
FS echo 1W (%) 55.3 ±1.6
† 43.2 ±4.2
∗,† 37.7 ±5.9
∗
FS MRI 1W (%) 50.7 ±2.4
† 39.1 ±5.4
∗,† 32.2 ±10.2
∗
FAC 1 W (%) 59.6 ±6.1
† 46.4 ±2.8
∗,† 36.9 ±8.8
∗
Troponin T (ng/ml) 0.1 ±0.12 .4 ± 0.7
∗ 3.8 ±2.0
∗
5.Conclusions
Mouse models are an important tool in cardiac research, and
imaging of the mouse heart is challenging but crucial. In the
presentstudywecouldshowthatadaptingacommonclinical
MRI scanner is a feasible method to determine infarct size
and functional data of mouse hearts in vivo.
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